Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105037245A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Saxagliptin intermediate via CN105037245A. High purity, scalable process for DPP-4 inhibitor manufacturing supply chain optimization and cost efficiency.